Peripheral Arterial Disease Trial, Recruiting NCT04788914 Sponsor: National Taiwan University Hospital Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT04788914
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

As a patient participant:

  • People who are older than 20 years of age at the time of screening.
  • People who have chronic kidney disease with a moderate reduction in kidney function (a specific kidney filtering measure called eGFR must be between 15 and 60), and whose kidney function has been stable for at least 30 days before joining.
  • People who have peripheral artery disease (reduced blood flow in the limbs) with symptoms rated at a certain level of severity, confirmed by specific tests such as blood pressure measurements in the ankle and leg, or imaging scans.

As a control group participant (for comparison purposes):

  • People who are older than 20 years of age at the time of screening.
  • People whose kidney function is in the normal range (eGFR above 60).
  • People who do not have peripheral artery disease.

Who may not be able to join:

  • People whose kidney function is very severely reduced (eGFR below 15).
  • People who are severely malnourished, shown by a very low albumin (protein) level in the blood (below 2.0 g/dL).
  • People with severe anaemia or active bleeding in the digestive tract, shown by a very low haemoglobin level (below 8 g/dL).
  • People who have a peptic ulcer, swollen veins in the oesophagus (food pipe), a bowel blockage, or who are currently not eating or drinking.
  • People who have previously had surgery on their digestive system.
  • People who have chronic constipation — defined as fewer than 3 bowel movements per week, straining, hard stools, feeling of incomplete emptying, or being unable to pass stool — unless laxatives are able to produce a bowel movement, in which case this condition may not be an obstacle (confirm with trial site).
  • People who have had a major bleeding event requiring a blood transfusion during their current hospital admission.
  • People who have been diagnosed with advanced liver cirrhosis (Child classification B or C), either confirmed by biopsy or by a doctor's clinical assessment.
  • People who have received a solid organ transplant or a blood/bone marrow transplant.
  • People who are producing very little urine (less than 500 mL per day), indicating a type of acute kidney injury.
  • People whose kidney problems are caused by a blockage in the urinary system or by polycystic kidney disease (an inherited condition where cysts grow on the kidneys).
  • People who have taken antibiotics or probiotic supplements within the 2 weeks before joining the trial, or who would need to take them during the follow-up period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chau chung Wu, National Taiwan University Hospital

Phone: 02-23123456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 April 2020
Est. completion
30 December 2024

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

The change of the six-minute walk test; The change of ABI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov